M

Moderna

D

MRNA

USD

1.2

(1.0875%)

Market Closed

209,907.00

حجم التداول

-6.78

الربح لكل سهم

-

العائد الربحي

-9.090024

P/E

42,706,391,922.48

حجم السوق

اليوم

1.0875%

1 اسبوع

2.500%

1 شهر

5.615%

6 اشهر

46.301%

12 اشهر

-16.362%

بداية السنة

12.112%

كل الوقت

637.211%

التوصيات

أصول ذات صلة

Title:
Moderna

Sector:

Healthcare

Industry:

Biotechnology

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

هل تحتاج مساعدة او لديك استفسار؟

تواصل معنا